Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-09

Clinical Trial Update: Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

View source ↗

Summary

A long-term (12-month) special surveillance trial of candesartan cilexetil/hydrochlorothiazide combination tablets in hypertension has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Candesartan Cilexetil/Hydrochlorothiazide Combination Tablets (candesartan cilexetil / hydrochlorothiazide)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Status: COMPLETED | Results posted: 2018-11-09